Cargando…
Correction: A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer
Autores principales: | Schweizer, Michael T., Haugk, Kathleen, McKiernan, Jožefa S., Gulati, Roman, Cheng, Heather H., Maes, Jessica L., Dumpit, Ruth F., Nelson, Peter S., Montgomery, Bruce, McCune, Jeannine S., Plymate, Stephen R., Yu, Evan Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093693/ https://www.ncbi.nlm.nih.gov/pubmed/30110398 http://dx.doi.org/10.1371/journal.pone.0202709 |
Ejemplares similares
-
A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer
por: Schweizer, Michael T., et al.
Publicado: (2018) -
Activity of enzalutamide in men with metastatic castration resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel
por: Cheng, Heather H., et al.
Publicado: (2015) -
Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer
por: Kang, Borui, et al.
Publicado: (2023) -
Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer
por: Parikh, Mamta, et al.
Publicado: (2021) -
Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan
por: Yokomizo, Akira, et al.
Publicado: (2021)